Fujifilm Diosynth Biotechnologies

Last updated

FUJIFILM Diosynth Biotechnologies, abbreviated and often referred to as FDB, is a biopharmaceutical contract manufacturing organization that develops manufacturing processes and manufactures active ingredients and provides fill and finish services for pharmaceutical companies. [1] FUJIFILM Diosynth Biotechnologies is the world's second largest contract manufacturer of biopharmaceuticals, with manufacturing facilities in Morrisville, North Carolina and College Station, Texas in the United States, Teesside, United Kingdom and Hillerød, Denmark in Europe, and recently added sites in Thousand Oaks, California and Watertown, Massachusetts. [2] FUJIFILM Diosynth Biotechnologies operates a highly automated multipurpose manufacturing facility in College Station, Texas [3] under the federal government's Center for Innovation in Advanced Development and Manufacturing (CIADM) program, which is the largest scale-out cell culture manufacturing facility in the United States. [4]

Contents

In March 2021, the company announced that it had selected Holly Springs, North Carolina, located near its existing operations in Morrisville, for a $2 billion investment to establish a new large-scale cell culture production site, which is expected to be operational in 2025 and create 725 new jobs by the end of 2028. The company plans to install 8 x 20,000L bioreactors at the facility and plan for the ability to add an additional 24 x 20,000L bioreactors, as well as production lines for large scale automated fill and finish, labeling, and packaging services. [5] [6] [7]

History

Early history

The company started in Oss, Netherlands in 1923 with the extraction of insulin from bovine pancreata, and porcine insulin extraction in 1930. [8] [9] [10] In January 2005, the company became a part of Organon, one of its sister companies in the Akzo Nobel pharma group. [11] Along with its sister companies Organon and Intervet were sold to Schering-Plough in March 2007 by Akzo Nobel. [12] Following the mergers of Schering-Plough with Merck & Co. (MSD) on March 9, 2009, [13] the company temporarily became part of the MSD Nutritionals products company, belonging to the MSD group. [14]

In April 2011, the company was sold to Fujifilm, forming Fujifilm Diosynth Biotechnologies. [15] For most of the company's history, Diosynth manufactured biochemical substances and fine chemicals, with pharmaceutical raw materials coming largely from either animal origin or chemical intermediates. Under Fujifilm, it no longer focuses on small molecules, but instead develops processes for and mass manufactures biologics (e.g., proteins and mRNA). On December 18, 2014, Fujifilm Diosynth Biotechnologies acquired Kalon Biotherapeutic Technologies in College Station, TX, which became Fujifilm Diosynth Biotechnologies Texas. [16] [17]

In March 2020, Fujifilm Diosynth Biotechnologies named Martin Meeson the company's new CEO. He took over from Steve Bagshaw who was set to retire and became a non-executive chairman. [18] In June 2023, Lars Petersen succeeded Martin Meeson as the new CEO. [19]

Subject to regulatory approval, at least 60 million doses of the Novavax COVID-19 vaccine will be manufactured for the UK government from 2021 by Fujifilm Diosynth Biotechnologies at its Billingham site. [20] [21]

Related Research Articles

<span class="mw-page-title-main">Fujifilm</span> Japanese conglomerate started as photographic film manufacturer

Fujifilm Holdings Corporation, trading as Fujifilm, or simply Fuji, is a Japanese multinational conglomerate headquartered in Tokyo, Japan, operating in the areas of photography, optics, office and medical electronics, biotechnology, and chemicals.

<span class="mw-page-title-main">Merck Group</span> German multinational science and technology company

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.

Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it became an independent company. In 1971, the Schering Corporation merged with Plough, Inc. to form Schering-Plough. On November 4, 2009 Merck & Co. merged with Schering-Plough with the new company taking the name of Merck & Co.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Cambrex Corporation</span> American pharmaceutical company

Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets for API and dosage form development and manufacturing.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

<span class="mw-page-title-main">Genedata</span> Swiss bioinformatics company

Genedata is a bioinformatics company that develops enterprise software solutions to accelerate biopharmaceutical research and development. Founded in 1997 by Othmar Pfannes, Genedata has since grown to approximately 400 employees. Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo positioning the company in the heart of biopharma clusters around the globe.

A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

<span class="mw-page-title-main">Wockhardt</span> Pharmaceutical and biotechnology company headquartered in Mumbai, India

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

<span class="mw-page-title-main">Biological E. Limited</span> Indian biopharmaceutical company

Biological E Limited is an Indian biotechnology and biopharmaceutical company based in Hyderabad, Telangana. It specialises in the areas of low-cost vaccine production.

<span class="mw-page-title-main">Novavax</span> American biotechnology company

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.

Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. In 2016, the company changed their strategic focus and became a biologics contract development and manufacturing company (CDMO) specializing in the manufacturing of vaccines, monoclonal antibodies, recombinant proteins, virus and nucleic acids.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.

<span class="mw-page-title-main">Bharat Biotech</span> Indian multinational biotechnology company and vaccine manufacturer

Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.

<span class="mw-page-title-main">Novavax COVID-19 vaccine</span> Vaccine against COVID-19

The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. It contains a recombinant spike protein from the SARS-CoV-2 Omicron variant lineage JN.1.

Rentschler Biopharma SE is a contract development and manufacturing organization (CDMO). It is part of Dr. Rentschler Holding GmbH & Co. KG and its employees make up the majority of the 1300 workers employed by the parent organization.

References

  1. ↑ "Global CDMO". FUJIFILM Diosynth Biotechnologies. Retrieved 2022-08-12.
  2. ↑ "Our Facilities". FUJIFILM Diosynth Biotechnologies. Retrieved 2022-08-12.
  3. ↑ Carr, Teresa (2021-04-09). "This COVID-19 Vaccine Plant Shows Texas Is Becoming Biotech's Third Coast". Texas Monthly. Retrieved 2022-08-12.
  4. ↑ "FUJIFILM Diosynth Biotechnologies Begins Production of Two COVID-19 Vaccines Candidates at Texas Facility". NBC 5 Dallas-Fort Worth. Retrieved 2022-08-12.
  5. ↑ "Fujifilm Selects North Carolina as the Location to Build the Largest Cell Culture Biopharmaceutical CDMO Facility in North America | Fujifilm [United States]". FUJIFILM Corporation. 18 March 2021. Retrieved 2022-08-12.
  6. ↑ Ohnesorge, Lauren (18 March 2021). "Fujifilm Diosynth Biotechnologies picks Wake town for 725-job facility". Triangle Business Journal. Retrieved 2022-08-12.
  7. ↑ Ohnesorge, Lauren (26 September 2021). "Behind the deal: How Holly Springs beat Texas for Fujifilm's $2B, 725-job project". Triangle Business Journal. Retrieved 2022-08-12.
  8. ↑ "Diosynth Company History". Diosynth. Archived from the original on 11 May 2010. Retrieved 19 June 2010.
  9. ↑ "Diosynth and Biochemistry". Diosynth. Archived from the original on 18 December 2003. Retrieved 19 June 2010.
  10. ↑ "Diosynth-Usine Saint Charles, France-Insulin Extraction Plant". Vanelk. Retrieved 22 June 2010.
  11. ↑ "81 Years of Organon at a Glance". Organon. Archived from the original on 9 March 2005. Retrieved 19 June 2010.
  12. ↑ "Schering-Plough Acquires Organon BioSciences". Medical Net News. 20 November 2007. Retrieved 19 June 2010.
  13. ↑ Singer (10 March 2010). "Merck to Buy Schering-Plough for $41 Billion". New York Times. Retrieved 19 June 2010.
  14. ↑ Communication from one employee, no reference found on the web site, but a presentation of Diosynth france company (modified April 2012)
  15. ↑ "Company History". Fujifilm. Retrieved 2013-12-04.
  16. ↑ "Fujifilm completes acquisition of Kalon Biotherapeutics". FUJIFILM Diosynth Biotechnologies. 2014-12-18. Retrieved 2022-08-12.
  17. ↑ "FUJIFILM Completes Acquisition of Kalon Biotherapeutics". BioProcess International. 2014-12-20. Retrieved 2022-08-12.
  18. ↑ "New CEO takes over as Fujifilm Diosynth Biotechnologies expands". FiercePharma. Retrieved 2020-03-11.
  19. ↑ "Fujifilm Appoints Lars Petersen as President & CEO of FUJIFILM Diosynth Biotechnologies, leading Global Bio CDMO". Fujifilm. Retrieved 2024-06-04.
  20. ↑ Boseley, Sarah; Davis, Nicola (28 January 2021). "Novavax Covid vaccine shown to be nearly 90% effective in UK trial". The Guardian. Retrieved 29 January 2021.
  21. ↑ Brown, Mike (14 August 2020). "60m doses of new covid-19 vaccine could be made in Billingham - and be ready for mid-2021". TeessideLive. Reach. Retrieved 29 January 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.